← Open Payments lookup

RAMESH PARCHURI: Open Payments

NPI 1437224300 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,238 in 64 payments from 17 companies in 2025. Trend: 2023 $1,309 · 2024 $974 · 2025 $1,238

Food & beverage: $1,238
CompanyPaymentsAmount
GlaxoSmithKline, LLC.26$358
Boehringer Ingelheim Pharmaceuticals, Inc.6$155
E.R. Squibb & Sons, L.L.C.5$119
AstraZeneca Pharmaceuticals LP5$100
Verona Pharma, Inc.3$87
ABBVIE INC.3$69
Astellas Pharma US Inc2$50
Lilly USA, LLC2$48
Vanda Pharmaceuticals Inc.2$44
Bayer Healthcare Pharmaceuticals Inc.2$38

Products named: TRELEGY ELLIPTA, JARDIANCE, COBENFY, Ohtuvayre, VRAYLAR, Veozah, FANAPT, FARXIGA.

Industry payments across PA — which companies pay providers there.